References
- Trends in chronic obstructive bronchitis and emphysema: morbidity and mortality. American Lung Association Epidemiology & Statistics Unit Research and Program Services, 2006
- Healthy People 2010 (conference edn., vol II). In: US Department of Health and Human Services W, DC, ed. 2000
- Kardos P, Wencker M, Glaab T, et al. Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:144-9
- Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005;143:317-26
- Stempel DASR, Kim J, Chernicoff HO, et al. Asthma related ED/hospitalization risk and asthma costs of fluticasone propionate/salmeterol in a single inhaler compared to fluticasone propionate and salmeterol in separate inhalers. J Allergy Clin Immunol 2004;113:S272
- Trends in asthma: morbidity and mortality. American Lung Association Epidemiology & Statistics Unit Research and Program Services, 2006
- Silva GE, Sherrill DL, Guerra S, et al. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126:59-65
- Beeh KM, Kornmann O, Beier J, et al. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 2004;98:591-7
- Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Int Med 2000;160:1683-9
- OCR privacy brief: summary of the HIPAA privacy rule. In: OFCR-HIPPA, ed.: Department of Health and Human Services, Office for Civil Rights, 2007
- International Classification of Diseases, 9th Revision, Clinical Modification, 4th Edn. In: USDHHS, ed.: US Government Printing Office, Washington, DC. 1991
- National Drug Code Directory. 2007. Available at: http://www.fda.gov/cder/ndc/index.htm (Last accessed April 14, 2009)
- Fan VS, Bryson CL, Curtis JR, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med 2003;168:1488-94
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
- SAS. SAS/STAT User's Guide, Version 9. 9th Edn. Cary, NC: SAS Institute, Inc., 2003
- Bleecker ER. Similiarities and differences in asthma and COPD: the Dutch Hypothesis. Chest 2004;126 (Suppl.):93S-95S
- Nathell L, Larsson K, Jensen I. Determinants of undiagnosed asthma. Allergy. 2002;57:687-93